The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Patients' preferences within randomised trials: systematic review and patient level meta-analysis
Open accessAbstract
OBJECTIVE: To systematically review fully randomised patient preference trials and to explore the impact of preferences on attrition and outcome by meta-analysis of patient level data. DATA SOURCES: Citation search using Science Citation Index and Google Scholar and search of the main electronic databases (Medline, CINAHL, Embase, and AMED) with a combination of key words. STUDY SELECTION: Fully randomised patient preference trials that compared treatments for any clinical condition were included. Other types of preference trials and crossover trials were excluded. Other inclusion criteria: participants aged 16 years and over; primary, self-reported outcomes measured on a continuous numerical scale. From 167 studies identified and screened, 17 were identified as fully randomised patient preference trials. DATA SYNTHESIS: Of the 17 trials identified, 11 authors provided raw data for the meta-analysis. Data collected were baseline and follow-up data for the main outcome, randomised allocation data, preference data, and demographic data. Baseline and first post-intervention follow-up data for the main outcome were standardised. To improve homogeneity, data for only the eight musculoskeletal trials (n=1594) were combined. To estimate the effects of preferences on outcomes and attrition, three groups were compared: patients who had a preference and were randomly allocated to their preferred treatment; patients who had a preference and were randomly allocated to the treatment they did not prefer; and patients who had no preference. RESULTS: Patients who were randomised to their preferred treatment had a standardised effect size greater than that of those who were indifferent to the treatment assignment (effect size 0.162, 95% confidence interval 0.011 to 0.314; P=0.04). Participants who received their preferred treatment also did better than participants who did not receive their preferred treatment (effect size 0.152, -0.035 to 0.339), although this was not statistically significant (P=0.11). Participants allocated to their undesired treatment had outcomes that were no different from those who were indifferent. Participants who were allocated to their undesired treatment were less likely to be lost to first follow-up compared with indifferent participants (odds ratio 1.70, 1.076 to 2.693; P=0.02). No difference was found in attrition between patients allocated to their preference and those who were indifferent. CONCLUSIONS: Preferences among patients in musculoskeletal trials are associated with treatment effects. In open randomised trials, preferences should be ascertained before randomisation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Unützer, J., Katon, W., Callahan, C. M., Williams, Jr., Hunkeler, E., Harpole, L., Hoffing, M., Della Penna, R. D., Noël, P. H., Lin, E. H. B., et al. (2002) · JAMA · doi:10.1001/jama.288.22.2836 · Cited by 2,405
Clinical trials: A practical approach
Daly, M. J. (1984) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(84)90515-7 · Cited by 1,053
UK BEAM Trial Team (2004) · BMJ · doi:10.1136/bmj.38282.669225.ae · Cited by 518
Patient preferences and randomised clinical trials.
Brewin, C. R., & Bradley, C. (1989) · BMJ · doi:10.1136/bmj.299.6694.313 · Cited by 503
Shapiro, D. A., Barkham, M., Rees, A., Hardy, G. E., Reynolds, S., & Startup, M. (1994) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.62.3.522 · Cited by 485
Sherman, K. J., Cherkin, D. C., Erro, J., Miglioretti, D. L., & Deyo, R. A. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-12-200512200-00003 · Cited by 480
Understanding controlled trials: What is a patient preference trial?
Torgerson, D., & Sibbald, B. (1998) · BMJ · doi:10.1136/bmj.316.7128.360 · Cited by 304
King, M., Nazareth, I., Lampe, F., Bower, P., Chandler, M., Morou, M., Sibbald, B., & Lai, R. (2005) · JAMA · doi:10.1001/jama.293.9.1089 · Cited by 275
King, M., Nazareth, I., Lampe, F., Bower, P., Chandler, M., Morou, M., Sibbald, B., & Lai, R. (2005) · Health Technology Assessment · doi:10.3310/hta9350 · Cited by 164
Patients' preferences and randomised trials
Silverman, W. A., & Altman, D. G. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90347-5 · Cited by 158
Cited by
McHugh, R. K., Whitton, S. W., Peckham, A. D., Welge, J. A., & Otto, M. W. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12r07757 · Cited by 800
Relton, C., Torgerson, D., O'Cathain, A., & Nicholl, J. (2010) · BMJ · doi:10.1136/bmj.c1066 · Cited by 518
Treatment selection in depression.
Cohen, Z. D., & DeRubeis, R. J. (2018) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050817-084746 · Cited by 435
Freedland, K. E., Mohr, D. C., Davidson, K. W., & Schwartz, J. E. (2011) · Psychosomatic Medicine · doi:10.1097/psy.0b013e318218e1fb · Cited by 369
Guidelines for controlled trials of drugs in migraine: Third edition. A guide for investigators
International Headache Society Clinical Trials Subcommittee members:, Tfelt-Hansen, P., Pascual, J., Ramadan, N., Dahlöf, C., D'Amico, D., Diener, H.-C., Hansen, J. M., Lanteri-Minet, M., Loder, E., et al. (2012) · Cephalalgia · doi:10.1177/0333102411417901 · Cited by 365
Metadata
- Authors
- Preference Collaborative Review Group
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2008-10-31
- Volume
- 337
- Issue
- oct31 1
- Pages
- a1864-a1864
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W1560595865
- Cited by
- 301
- References
- 21
- FWCI
- 2.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Patients' preferences within randomised trials: systematic review and patient level meta-analysis. https://app.cochat.ai/papers/10.1136/bmj.a1864
- The paper
- Preference Collaborative Review Group. (2008). Patients' preferences within randomised trials: systematic review and patient level meta-analysis. BMJ. https://doi.org/10.1136/bmj.a1864
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.